BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1973428)

  • 1. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y.
    Wheldon TE; O'Donoghue JA; Barrett A; Michalowski AS
    Radiother Oncol; 1991 Jun; 21(2):91-9. PubMed ID: 1866470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-energy electron emitters for targeted radiotherapy of small tumours.
    Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
    Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.
    O'Donoghue JA; Bardiès M; Wheldon TE
    J Nucl Med; 1995 Oct; 36(10):1902-9. PubMed ID: 7562062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour therapy with radionuclides: assessment of progress and problems.
    Carlsson J; Forssell Aronsson E; Hietala SO; Stigbrand T; Tennvall J
    Radiother Oncol; 2003 Feb; 66(2):107-17. PubMed ID: 12648782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted radiotherapy using Auger electron emitters.
    O'Donoghue JA; Wheldon TE
    Phys Med Biol; 1996 Oct; 41(10):1973-92. PubMed ID: 8912375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for systemic radiotherapy of micrometastases using antibody-targeted 131I.
    Wheldon TE; O'Donoghue JA; Hilditch TE; Barrett A
    Radiother Oncol; 1988 Feb; 11(2):133-42. PubMed ID: 3281188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide therapy in oncology.
    Clarke SE
    Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the radiobiology of ytterbium-169 and iodine-125 permanent brachytherapy implants.
    Lazarescu GR; Battista JJ
    Phys Med Biol; 1997 Sep; 42(9):1727-36. PubMed ID: 9308079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters.
    Nahum AE
    Phys Med Biol; 1996 Oct; 41(10):1957-72. PubMed ID: 8912374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiological modeling of combined targeted 131I therapy and total body irradiation for treatment of disseminated tumors of differing radiosensitivity.
    Amin AE; Wheldon TE; O'Donoghue JA; Barrett A
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):323-30. PubMed ID: 8407407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical animal research on therapy dosimetry with dual isotopes.
    Konijnenberg MW; de Jong M
    Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S19-27. PubMed ID: 21484379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
    Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
    Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd.
    Antipas V; Dale RG; Coles IP
    Phys Med Biol; 2001 Oct; 46(10):2557-69. PubMed ID: 11686275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting radiation to tumours.
    Wheldon TE
    Int J Radiat Biol; 1994 Jan; 65(1):109-16. PubMed ID: 7905903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of targeted radiotherapy in clinical practice.
    Gaze MN
    Phys Med Biol; 1996 Oct; 41(10):1895-903. PubMed ID: 8912369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.